Nalaganje...

The effect of natalizumab on disability score and relapse rate of multiple sclerosis patients: a prospective cohort study

Multiple sclerosis (MS) is a progressive immune-related disorder of the central nervous system leading to destruction of myelin sheaths. Natalizumab is a humanized monoclonal antibody against the cell adhesion molecule α4-integrin which has been approved for treatment of relapsing forms of MS. This...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Clin Transl Med
Main Authors: Mazdeh, Mehrdokht, Hosseini, Shno, Taheri, Mohammad, Ghafouri-Fard, Soudeh
Format: Artigo
Jezik:Inglês
Izdano: Springer Berlin Heidelberg 2018
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6265353/
https://ncbi.nlm.nih.gov/pubmed/30498920
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40169-018-0216-3
Oznake: Označite
Brez oznak, prvi označite!